Joseph W. St. Geme, MD, Physician-in-Chief and Chairman of the Department of Pediatrics at Children’s Hospital of Philadelphia (CHOP) and Andrew J. Bauer, MD, Medical Director of the Pediatric Thyroid Center and Professor of Pediatrics at CHOP, recently received accolades at the 27th Annual Penn Medicine Awards of Excellence during a reception held at the Penn Museum on February 1, 2023 by the Perelman School of Medicine at the University of Pennsylvania.

Read this case study about integrating precision medicine into the standard of care for children with thyroid cancer.

When radioactive iodine is spared, there is no decrease in the likelihood of remission.

CHOP researchers have defined a 3-tiered molecular classification of pediatric differentiated thyroid cancer, where fusion oncogenes predict the most invasive behavior.

In a study in JAMA Otolaryngology, CHOP researchers propose treating invasive pediatric thyroid cancer with targeted oncogene therapy before or instead of surgery.

A unique CHOP clinic treats kids with radioactive iodine-refractory thyroid cancer.

A 5-year-old boy presents for an annual well visit. His parents report he has recently had an increased appetite along with increased energy levels and that he constantly complains about being warm with occasional complaints that his heart is “beating fast.”

Of nearly 500 patients seen at CHOP’s Pediatric Thyroid Center, very few needed to return to the OR, according to new research.

The American Thyroid Association released its first guidelines for evaluating and managing thyroid nodules and thyroid cancer in children.